Jiangsu Hansoh Pharmaceutical Co., Ltd.
Clinical trials sponsored by Jiangsu Hansoh Pharmaceutical Co., Ltd., explained in plain language.
-
New weight loss drug shows promise in large trial
Disease control CompletedThis study tested a new medicine called HS-20094 to help overweight and obese adults lose weight. About 600 people took either the drug or a placebo for up to 52 weeks. The main goals were to see how much weight they lost and how many lost at least 5% of their starting weight.
Phase: PHASE3 • Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 16, 2026 12:48 UTC
-
New weight loss drug HS-20094 tested in 200-Person trial
Disease control CompletedThis study tested a new drug called HS-20094 in 200 overweight or obese adults to see if it helps reduce body weight. Participants took the drug or a placebo for up to 32 weeks, along with diet and exercise. The goal was to measure weight change and check for side effects.
Phase: PHASE2 • Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 15, 2026 19:04 UTC
-
New schizophrenia drug shows promise in reducing symptoms
Symptom relief CompletedThis study tested a new medication called HS-10380 in 363 Chinese adults hospitalized with acute schizophrenia. The goal was to see if it reduces symptoms like hallucinations and delusions better than a placebo or an existing drug. Participants took the drug for 6 weeks, and doct…
Phase: PHASE2 • Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Jun 16, 2026 12:48 UTC